
Vivos Therapeutics Secures $7.5 Million Investment and Embarks on Strategic Alliance for Enhanced OSA Treatment
Vivos Therapeutics, Inc. (NASDAQ: VVOS), a leader in medical devices for sleep-related breathing disorders, has announced two major developments. The company has secured a $7.5 million equity investment from Seneca Partners and formed a strategic marketing and distribution alliance with a sleep treatment provider in Colorado. These initiatives aim to boost Vivos’ revenue and expand the reach of its innovative obstructive sleep apnea (OSA) treatments.
The alliance marks a shift in Vivos’ marketing strategy, integrating its FDA-cleared CARE oral devices and advanced therapies with the sleep provider’s services. Initial operations will begin in two Colorado sleep centers in July 2024, with plans for nationwide expansion. Kirk Huntsman, CEO of Vivos, highlighted the significance of the partnership: “This alliance is crucial for Vivos’ future, providing a scalable model to offer non-surgical OSA solutions to more patients.”
The $7.5 million investment from Seneca Partners strengthens Vivos’ financial position and supports the new alliance. The investment includes 3,220,266 shares of common stock and warrants. Michael Skaff, Managing Director of Seneca, stated: “We believe in Vivos’ potential to address the significant health challenges of OSA with their innovative treatments.”
Vivos aims to eliminate cash burn and achieve profitability through this new model, which reduces patient acquisition costs and increases gross profit per case. The collaboration with Seneca Partners, who will also provide management advisory services, supports these goals.
For more information about Vivos Therapeutics and its solutions, visit www.vivos.com.
To learn more about this exciting partnership, click here to read the full article.
About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. develops non-surgical, cost-effective treatments for breathing and sleep disorders, effective in over 42,600 patients worldwide.
About Seneca Partners
Seneca Partners is a private equity sponsor based in Michigan, specializing in adding value through active involvement and deep industry expertise.
Previous post